{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03425",
    "Peptide Name": "Nigrocin-PN (UCSS1a; likely natural AMPs; Gly-rich; frog, amphibians, animals; derivatives: Nigrocin-M1; Nigrocin-M2: inactive)",
    "Source": "Pelophylax nigromaculatus, Asia",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GLLGKILGAGKKVLCGVSGLC",
    "Sequence Length": 21,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal",
      "Anti-MRSA",
      "Antibiofilm",
      "Anticancer"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -1.31,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "52%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "APD analysis reveals this sequence is most similar (85.71%) toNigrocin-2G: 29%; L: 24%; K: 14%; Mol formula:  C88H160N24O23S2; Mol Wt: 1986.51; Mol Ex Coeff: 125; GRAVY: 1.13.Activity: active against Gram+ S. aureus NCTC 10,788 (MIC 4 uM), S. aureus ATCC 25,923 (MIC 16 uM), MRSA NCTC 12,493, MRSA B038 V1S1A, MRSA B042 V2E1A (MIC 16-32 uM), E. faecalis NCTC 12,697 (MIC 8 uM), S. constellatus B003 VISIT (MIC 8 uM), Gram- E. coli NCTC 10,418 (MIC 8 uM), K. pneumoniae ATCC 13,883, K. pneumoniae ATCC 43,816 (MIC 16 uM), P. aeruginosa ATCC 27,853, P. aeruginosa ATCC 9097 (MIC 64 uM), P. aeruginosa B004 V2S2B (MIC 16 uM), and fungus C. albicans NYCY 1467 (MIC 32 uM). Also showed effects on MRSA biofilms. It also has an effect on cancer cells (H157, PC-3, and U251MG).Structure:  helical in 50% TFE.Animal model:mouse:  lung infection: NigrocinPN caused a CFU drop in BALF of lung of K. pneumoniae-infected mice at 20.0 mg/kg.",
    "Author": "Chengyu Lu, Lingling Liu, Chengbang Ma, Liuqing Di, Tianbao Chen 2022",
    "Reference": "Journal of Genetic Engineering and Biotechnology 2022; 20:76.Publisher Web",
    "Title": "A novel antimicrobial peptide found\nin Pelophylax nigromaculatus"
  },
  "3D Structure": []
}